a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets
Industry Biotechnology
A.I.dvisor indicates that over the last year, HALO has been loosely correlated with CRSP. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then CRSP could also see price increases.
Ticker / NAME | Correlation To HALO | 1D Price Change % | ||
---|---|---|---|---|
HALO | 100% | -4.12% | ||
CRSP - HALO | 39% Loosely correlated | -4.61% | ||
BMRN - HALO | 36% Loosely correlated | +0.42% | ||
NTLA - HALO | 36% Loosely correlated | -3.65% | ||
KYMR - HALO | 35% Loosely correlated | -4.22% | ||
AVTE - HALO | 35% Loosely correlated | -3.63% | ||
More |
Ticker / NAME | Correlation To HALO | 1D Price Change % |
---|---|---|
HALO | 100% | -4.12% |
oncology theme (18 stocks) | 54% Loosely correlated | +0.37% |
cancer theme (87 stocks) | 42% Loosely correlated | +0.89% |
biotechnology theme (248 stocks) | 42% Loosely correlated | +5.56% |
drugs theme (265 stocks) | 41% Loosely correlated | +5.37% |
ophthalmology theme (8 stocks) | 28% Poorly correlated | +1.16% |
More |